Clinical trials
Hematologic Neoplasms trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 2 |
| Aprea Therapeutics | 1 |
| Axelar AB | 1 |
| Bristol-Myers Squibb | 1 |
| CellCentric Ltd. | 1 |
| Eli Lilly and Company | 1 |
| European Myeloma Network B.V. | 1 |
| Kiadis Pharma | 1 |
| Lund University Hospital | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 16 |
| Leukemia, Myeloid, Acute | 3 |
| Multiple Myeloma | 3 |
| Graft vs Host Disease | 2 |
| Leukemia | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Bone Marrow Diseases | 1 |
| COVID-19 | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myeloid | 1 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.